NCT06594198

Brief Summary

The main objective of this study is to show the concordance of the SctO2 values of the ARGOS platform with the standard SctO2 values (comparative study with platform INVOS, Medtronic).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2024

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

September 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2025

Completed
Last Updated

May 16, 2025

Status Verified

March 1, 2025

Enrollment Period

Same day

First QC Date

September 10, 2024

Last Update Submit

May 15, 2025

Conditions

Keywords

Brain MonitorARGOS PlatformSctO2ANIbcSEFEEG bispectral indexCerebral tissue oxygen saturationAnalgesia Nociception Index

Outcome Measures

Primary Outcomes (1)

  • Comparison of SctO2 values from ARGOS and INVOS

    Compare ARGOS and INVOS SctO2 values at different times of interest during the procedure. Compare ARGOS SctO2 values with invasive central venous and arterial saturation (measured by gasometry) during aortic unclamping. Compare INVOS SctO2 values with central venous and arterial saturation before, during and after aortic unclamping.

    During the surgical procedure

Secondary Outcomes (1)

  • ANI and Database

    During the surgical procedure

Study Arms (1)

One center and 40 patients

EXPERIMENTAL

Monitor the values of 3 brain parameters: SctO2, bcSEF and ANI measured by the ARGOS sensor.

Device: Cerebral monitor

Interventions

The study procedure consists of monitoring the values of 3 cerebral parameters: SctO2, bcSEF and ANI measured by the ARGOS sensor. These 3 parameters will be recorded and compared after the intervention with 3 parameters considered as standard: SctO2 measured by the INVOS 7100 cerebral oximeter, the bispectral index (BIS) measured by the BIS monitor and the ANI measured by the MDoloris monitor. These 3 reference parameters are once again usually monitored and recommended for all cardiac surgery.

One center and 40 patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient, male or female, over 18 years of age
  • Patient scheduled for cardiac surgery with programmed extracorporeal circulation (ECC)
  • Patient with no history of scalp injury or or skin diseases
  • Patient with an Euroscore 2 of less than 7%.
  • Patient affiliated or entitled to a social assurance

You may not qualify if:

  • Weight under 40 kg
  • Frontal surface too small to allow application of SctO2, BIS electrodes on the same hemifront
  • Patient with severe, unbalanced hypertension
  • Measurement of systolic blood pressure (SBP) \> 180 mm Hg and/or diastolic blood pressure (DBP) \> 110 mm Hg
  • Patients undergoing emergency surgery
  • Patient with chronic renal failure, with glomerular filtration \< 30 ml/min/1.73m², or requiring renal transplantation or requiring renal transplantation
  • Patient with left ventricular ejection fraction \< 40%
  • Patient with a history of ischemic stroke
  • Patients with preoperative sepsis
  • Patient requiring noradrenaline infusion noradrenaline infusion in the 24 hours prior to surgery
  • Patient with preoperative uni or bilateral carotid stenosis bilateral carotid stenosis \> 50%.
  • Protected patient: adult under guardianship, curatorship or legal protection, deprived of liberty by judicial or administrative decision.
  • Pregnant, parturient or breast-feeding women.
  • Patients hospitalized without consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique de la Sauvegarde

Lyon, 69009, France

Location

MeSH Terms

Interventions

Consciousness Monitors

Intervention Hierarchy (Ancestors)

Surgical EquipmentEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Single-centre, prospective, interventional clinical study
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2024

First Posted

September 19, 2024

Study Start

September 9, 2024

Primary Completion

September 9, 2024

Study Completion

March 3, 2025

Last Updated

May 16, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations